Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofpironium Bromide Gel 15% in Axillary Hyperhidrosis (CARDIGAN II)
NCT03948646Phase 3Completed
- Sponsor
- Botanix Pharmaceuticals
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofpironium in primary axillary hyperhidrosis (PAH), sponsored by Botanix Pharmaceuticals. Started Dec 2020; status: completed.
02
Drugs
sofpironium
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT03948646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948646.